“We’re very excited about 2024,” Horan said, pointing to a gradual recovery of cannabis stocks and the anticipation of significant legal changes that could stimulate the market further.
A Shift Towards Recovery
Analyzing Industry Challenges With Expertise
Drawing on his extensive background in the highly regulated healthcare sector, Horan sees many parallels between it and the cannabis industry. He highlighted specific challenges unique to cannabis, such as the 280e IRS tax code on company valuations and cash flow.
Horan, who sees scale and significant EBITDA as keys to success, says the cannabis industry is evolving towards traditional valuation metrics based on EBITDA – a trend that positions well-managed companies for lucrative exits or expansions.
Advising Preparation For A Changing Landscape
An Optimistic Outlook For Investors And Entrepreneurs
Horan's advice to cannabis investors and entrepreneurs is clear: now is an opportune time to engage with the market. “I’m accumulating,” he revealed, underscoring his belief in the sector’s imminent growth.
“This is an incredible time to get into the market and execute,” concluded Highway 33‘s managing partner, stressing the potential for both buyers and sellers in this rapidly evolving landscape.
To gain a detailed understanding and thorough analysis of the cannabis industry’s future direction, watch the complete episode of Benzinga’s Cannabis Insider on YouTube.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
